TWST | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 7%

Liquidity 75%

Performance 0%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

4.68%

1 Month

40.70%

3 Months

38.67%

6 Months

101.58%

1 Year

69.49%

2 Year

112.60%

Key data

Stock price

$62.61

P/E Ratio

0.00

DAY RANGE

$62.12 - $65.10

EPS

-$1.27

52 WEEK RANGE

$23.30 - $65.10

52 WEEK CHANGE

$66.43

MARKET CAP

1.940 B

YIELD

N/A

SHARES OUTSTANDING

61.312 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-01-2025

BETA

3.13

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,533,798

AVERAGE 30 VOLUME

$1,291,517

Company detail

CEO: Emily M. Leproust
Region: US
Website: twistbioscience.com
Employees: 990
IPO year: 2018

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.

TWST - Twist Bioscience Corp